drugset / Trial / NCT00990223

Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity

NCT00990223

Phase 1 Completed 20 enrolled Viatris Inc.
RandomizedSingle-groupDouble-blindOther

Summary

To evaluate the changes in serum aldosterone and plasma renin activity on Day 0 and on Days 1 and 10 after administration of 100 mg of eplerenone daily for 10 days.

Timeline

Start
2009-10
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown 100 mg

Indications

No indication recorded.